Teva outlook on stable prices buoys generics

|About: Teva Pharmaceutical In... (TEVA)|By:, SA News Editor

Generic drug makers are in the green after Teva Pharmaceutical Industries (TEVA +1.9%) chief Kåre Schultz stated that he sees stable prices this year, a welcome view considering the downward pressure last year. He made the comment during his presentation at the JP Morgan Healthcare Conference.

Selected tickers: (ACET +4.8%)(ACRS +2.2%)(AKRX +6.8%)(AMRX +0.2%)(ANIP +3.2%)(BHC +5.6%)(CHRS +17.5%)(ENDP +10%)(LCI +21.3%)(MNK +5.7%)(MYL +3.5%)(PRGO +3.9%)(TLGT +7%)


Subscribe for full text news in your inbox